| |
| |
|
| Insider
Information: |
Gonzalez Richard A |
| Relationship: |
|
| City: |
Abbott Park |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
704,674 |
|
|
Indirect Shares
|
55,155 |
|
|
| Direct
Value |
$99,556,210 |
|
|
|
Indirect Value
|
$7,193,519 |
|
|
| Total
Shares |
759,829 |
|
|
| Total
Value |
$106,749,729 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
6
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
| Percentage
Gain/Loss : |
0.0%
|
 67.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Abbott Laboratories |
ABT |
Executive Vice President |
2012-04-06 |
185,575 |
2007-09-30 |
25,740 |
Premium* |
|
|
Abbvie Inc. |
ABBV |
|
2024-02-28 |
519,099 |
2023-09-25 |
29,415 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ABBV |
Abbvie Inc. |
Chairman of the Board and CEO |
• • – |
2016-06-02 |
4 |
A |
$35.88 |
$10,259,994 |
D/D |
285,953 |
624,374 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Chairman of the Board and CEO |
• • – |
2016-06-02 |
4 |
S |
$63.80 |
$18,249,712 |
D/D |
(285,953) |
338,421 |
0 |
- |
|
| ABT |
Abbott Laboratories |
President and COO |
• • – |
2007-08-21 |
4 |
OE |
$33.23 |
$9,355,636 |
D/D |
281,530 |
688,950 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Chairman of the Board and CEO |
• – – |
2013-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
257,720 |
307,152 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
CHAIRMAN OF THE BOARD AND CEO |
• • – |
2023-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
256,901 |
760,154 |
0 |
- |
|
| ABT |
Abbott Laboratories |
President and COO |
• • – |
2007-09-18 |
4 |
OE |
$41.03 |
$10,896,783 |
D/D |
250,000 |
549,210 |
0 |
- |
|
| ABT |
Abbott Laboratories |
President and COO |
• • – |
2007-09-19 |
4 |
OE |
$33.23 |
$9,680,477 |
D/D |
249,178 |
548,388 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
CHAIRMAN OF THE BOARD AND CEO |
• • – |
2024-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
248,865 |
772,159 |
0 |
- |
|
| ABT |
Abbott Laboratories |
President and COO |
• • – |
2007-09-18 |
4 |
S |
$52.25 |
$12,214,504 |
D/D |
(233,300) |
315,910 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Chairman of the Board and CEO |
• • – |
2022-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
232,078 |
608,675 |
0 |
- |
|
| ABT |
Abbott Laboratories |
President and COO |
• • – |
2007-08-21 |
4 |
D |
$52.39 |
$11,483,469 |
D/D |
(219,192) |
469,758 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2012-02-22 |
4 |
OE |
$52.39 |
$11,483,469 |
D/D |
219,192 |
406,827 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Chairman of the Board and CEO |
• • – |
2017-11-21 |
4 |
OE |
$58.88 |
$12,847,204 |
D/D |
218,193 |
492,030 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Chairman of the Board and CEO |
• • – |
2017-11-21 |
4 |
S |
$94.01 |
$20,511,800 |
D/D |
(218,193) |
273,837 |
0 |
- |
|
| ABT |
Abbott Laboratories |
Executive Vice President |
• – – |
2012-02-22 |
4 |
S |
$56.17 |
$11,737,059 |
D/D |
(208,926) |
197,901 |
0 |
- |
|
| ABT |
Abbott Laboratories |
President and COO |
• • – |
2007-09-13 |
4 |
S |
$52.25 |
$10,613,990 |
D/D |
(202,890) |
346,320 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Chairman of the Board and CEO |
• • – |
2020-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
200,262 |
527,236 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Chairman of the Board and CEO |
• • – |
2020-11-12 |
4 |
OE |
$54.86 |
$11,089,858 |
D/D |
194,154 |
512,796 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Chairman of the Board and CEO |
• • – |
2020-11-12 |
4 |
S |
$97.06 |
$18,851,790 |
D/D |
(194,154) |
318,642 |
0 |
% |
|
| ABBV |
Abbvie Inc. |
Chairman of the Board and CEO |
• • – |
2017-08-07 |
4 |
OE |
$51.42 |
$9,930,796 |
D/D |
193,131 |
469,623 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Chairman of the Board and CEO |
• • – |
2017-08-07 |
4 |
S |
$71.00 |
$13,713,186 |
D/D |
(193,131) |
276,492 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Chairman of the Board and CEO |
• • – |
2015-04-28 |
4 |
OE |
$35.88 |
$6,296,115 |
D/D |
175,477 |
657,624 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Chairman of the Board and CEO |
• • – |
2021-12-09 |
4 |
S |
$122.80 |
$21,453,641 |
D/D |
(174,100) |
376,597 |
0 |
% |
|
| ABBV |
Abbvie Inc. |
Chairman of the Board and CEO |
• • – |
2021-12-09 |
4 |
OE |
$61.36 |
$10,682,776 |
D/D |
174,100 |
550,697 |
0 |
- |
|
| ABBV |
Abbvie Inc. |
Chairman of the Board and CEO |
• • – |
2021-03-01 |
4 |
S |
$108.61 |
$18,476,204 |
D/D |
(170,113) |
376,597 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
